UK's ImmuPharma gains on collaboration with Orano for cancer treatment
06/03/2023 09:48
** Shares of pharmaceutical firm ImmuPharma IMM.L rise as
much as 9% to 2.5p
** Stock among top pct gainers on FTSE All Share index
.FTAS
** ImmuPharma signs collaboration agreement with French
nuclear energy company Orano SA for cancer radiotherapy via
IMM's peptide technology
** IMM to provide its peptide technology, which enters
nucleus of cancer cells and treat them via radioactive isotopes
with minimal impact on surrounding tissue
** Orano has paid a small, undisclosed amount for the
12-month collaboration to identify suitable radiotherapy
candidates for treatment of cancer - ImmuPharma
** Including session's gains, stock has risen ~39% YTD
(Reporting by Sruthi Narasimha Chari in Bengaluru)
((Sruthinarasimha.chari@thomsonreuters.com))